APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

Healthcare Services

Sharesguru Stock Score

APOLLOHOSP

43/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹8362.50+54.00(+0.65%)

Market Closed as of May 22, 2026, 15:30 IST

Select time range

Pros

Momentum: Stock price has a strong positive momentum. Stock is up 7.5% in last 30 days.

Smart Money: Smart money has been increasing their position in the stock.

Size: It is among the top 200 market size companies of india.

Past Returns: Outperforming stock! In past three years, the stock has provided 21.8% return compared to 8.9% by NIFTY 50.

Growth: Good revenue growth. With 52.2% growth over past three years, the company is going strong.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Balance Sheet: Strong Balance Sheet.

Profitability: Recent profitability of 8% is a good sign.

Cons

No major cons observed.

Valuation
Market Cap	1.2 LCr
Price/Earnings (Trailing)	61.63
Price/Sales (Trailing)	4.71
EV/EBITDA	31.59
Price/Free Cashflow	133.91
MarketCap/EBT	45.75
Enterprise Value	1.25 LCr

Fundamentals
Revenue (TTM)	25.42 kCr
Rev. Growth (Yr)	17.6%
Earnings (TTM)	2 kCr
Earnings Growth (Yr)	33%

Profitability
Operating Margin	10%
EBT Margin	10%
Return on Equity	19.53%
Return on Assets	8.5%
Free Cashflow Yield	0.75%

Growth & Returns
Price Change 1W	2.5%
Price Change 1M	7.5%
Price Change 6M	12.6%
Price Change 1Y	19.2%
3Y Cumulative Return	21.8%
5Y Cumulative Return	20.7%
7Y Cumulative Return	32.7%
10Y Cumulative Return	19.9%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-2.15 kCr
Cash Flow from Operations (TTM)	2.86 kCr
Cash Flow from Financing (TTM)	-477.6 Cr
Cash & Equivalents	811.3 Cr
Free Cash Flow (TTM)	423.7 Cr
Free Cash Flow/Share (TTM)	29.47

Balance Sheet
Total Assets	22.2 kCr
Total Liabilities	12.22 kCr
Shareholder Equity	9.97 kCr
Current Assets	6.9 kCr
Current Liabilities	6.48 kCr
Net PPE	11.04 kCr
Inventory	542.4 Cr
Goodwill	1.03 kCr

Capital Structure & Leverage
Debt Ratio	0.24
Debt/Equity	0.56
Interest Coverage	4.41
Interest/Cashflow Ops	5.74

Dividend & Shareholder Returns
Dividend/Share (TTM)	20
Dividend Yield	0.24%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Technical Indicators
RSI (14d)	81.46
RSI (5d)	75.47
RSI (21d)	68.07
MACD Signal	Buy
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Buy
RSI Signal	Sell
RSI5 Signal	Sell
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Description	Share	Value
Healthcare services	50.0%	3.3 kCr
Digital health & pharmacy distribution	42.7%	2.8 kCr
Retail health & diagnostics	7.3%	489.5 Cr
Total		6.7 kCr

Shareholder Name	Holding %
M/s. PCR Investments Ltd	18.93%
GOVERNMENT OF SINGAPORE	2.1%
Ms. Suneeta Reddy	2.04%
SBI NIFTY 50 ETF	1.86%
AXIS MUTUAL FUND TRUSTEE LIMITED	1.86%
MIRAE ASSET ELSS TAX SAVER FUND	1.81%
Ms. Sangita Reddy	1.69%
GOVERNMENT PENSION FUND GLOBAL	1.65%
Ms. Shobana Kamineni	1.56%
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED	1.48%
ICICI PRUDENTIAL BALANCED ADVANTAGE FUND	1.32%
NIPPON LIFE INDIA TRUSTEE LTD	1.28%
Mr. K Vishweshwar Reddy	1.1%
Ms. Preetha Reddy	0.73%
Ms. Sindoori Reddy	0.22%
Ms. Anuspala Kamineni	0.18%
Dr. Prathap C Reddy	0.17%
Mr. Vijay Kumar Reddy	0.16%
Mr. Konda Anindith Reddy	0.16%
Mr. Karthik Anand	0.16%

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
MAXHEALTH	Max Healthcare Institute	1.07 LCr	8.54 kCr	+7.30%	-4.10%	73.79	12.48	-	-
FORTIS	Fortis Healthcare	73.31 kCr	8.84 kCr	+5.90%	+44.50%	76.34	8.3	-	-
NH	Narayana Hrudayalaya	39.36 kCr	6.88 kCr	+6.80%	+10.60%	50.22	5.72	-	-
MEDANTA	Global Health	33.33 kCr	4.51 kCr	+14.70%	+4.80%	59.87	7.39	-	-
KIMS	Krishna Institute of Medical Sciences	30.85 kCr	3.93 kCr	+13.20%	+16.30%	128.07	7.85	-	-
LALPATHLAB	Dr. Lal Pathlabs	26.86 kCr	2.86 kCr	+16.50%	+18.00%	53	9.38	-	-
METROPOLIS	Metropolis Healthcare	10.96 kCr	1.67 kCr	+9.20%	+27.30%	57.63	6.56	-	-

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	15.8%	25,228	21,794	19,059	16,612	14,663	10,560
Other Income	-4%	192	200	106	90	78	45
Total Income	15.6%	25,420	21,994	19,166	16,703	14,741	10,605
Cost of Materials	10.4%	3,041	2,754	2,454	2,284	2,685	1,623
Purchases of stock-in-trade	17.5%	10,056	8,557	7,385	6,315	4,961	4,186
Employee Expense	8.3%	3,000	2,769	2,494	2,144	1,787	1,601
Finance costs	-1.8%	450	458	449	381	379	449
Depreciation and Amortization	15.6%	876	758	687	615	601	573
Other expenses	14.7%	5,383	4,693	4,369	3,845	3,118	2,137
Total Expenses	14%	22,785	19,988	17,805	15,559	13,457	10,445
Profit Before exceptional items and Tax	31.4%	2,635	2,006	1,361	1,144	1,284	160
Exceptional items before tax	-	-19.2	0	1.9	0	294	61
Total profit before tax	30.4%	2,616	2,006	1,362	1,144	1,578	221
Current tax	19.6%	629	526	437	406	238	76
Deferred tax	317.9%	29	7.7	8.7	-149.67	239	8.92
Total tax	23.3%	658	534	446	256	477	85
Total profit (loss) for period	33.1%	2,003	1,505	935	845	1,108	137
Other comp. income net of taxes	880.8%	58	-6.3	-10.4	-13.27	-9.72	15
Total Comprehensive Income	37.5%	2,061	1,499	925	831	1,099	152
Earnings Per Share, Basic	34.6%	135.04	100.56	62.5	56.97	73.42	10.74
Earnings Per Share, Diluted	34.5%	134.94	100.56	62.5	56.97	73.42	10.74

Description	(%) Q/Q	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024
Revenue From Operations	2%	6,606	6,477	6,304	5,842	5,592	5,527
Other Income	-17.3%	44	53	55	40	61	64
Total Income	1.8%	6,649	6,530	6,358	5,882	5,653	5,591
Cost of Materials	4.3%	777	745	779	740	694	626
Purchases of stock-in-trade	-1.9%	2,613	2,663	2,465	2,316	2,244	2,292
Employee Expense	3.1%	772	749	767	713	725	686
Finance costs	5.4%	119	113	110	108	115	110
Depreciation and Amortization	2.3%	224	219	218	215	211	185
Other expenses	2.8%	1,420	1,381	1,352	1,230	1,169	1,178
Total Expenses	1.6%	5,938	5,844	5,690	5,313	5,148	5,060
Profit Before exceptional items and Tax	3.6%	711	686	668	569	505	531
Exceptional items before tax	95%	0	-19.2	0	0	0	0
Total profit before tax	6.6%	711	667	668	569	505	531
Current tax	33.6%	196	147	162	125	119	134
Deferred tax	-248.9%	-25.8	19	19	17	-18	22
Total tax	2.4%	170	166	181	142	101	157
Total profit (loss) for period	6.8%	551	516	494	441	414	379
Other comp. income net of taxes	-325%	-4.1	-0.2	57	5.9	-3	-2.9
Total Comprehensive Income	6%	547	516	551	447	412	376
Earnings Per Share, Basic	5.5%	36.82	34.94	33.19	30.1	27.1	25.89
Earnings Per Share, Diluted	5.4%	36.76	34.94	33.19	30.1	27.1	25.89

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	13.7%	9,326	8,202	7,274	6,525	6,098	9,153
Other Income	6.9%	372	348	180	152	47	18
Total Income	13.4%	9,698	8,550	7,454	6,676	6,145	9,171
Cost of Materials	7.6%	2,419	2,248	1,999	1,861	1,929	1,330
Purchases of stock-in-trade	-	0	0	0	0	0	4,155
Employee Expense	5.6%	1,686	1,597	1,425	1,239	1,150	1,275
Finance costs	-4.7%	242	254	250	239	244	344
Depreciation and Amortization	11.4%	500	449	399	367	363	436
Other expenses	25.1%	2,893	2,313	2,052	1,743	1,599	1,573
Total Expenses	12.8%	7,740	6,861	6,125	5,449	5,286	8,985
Profit Before exceptional items and Tax	16%	1,958	1,688	1,329	1,228	859	186
Exceptional items before tax	-	-11.4	0	0	0	-6.74	-9.09
Total profit before tax	15.3%	1,946	1,688	1,329	1,228	852	177
Current tax	12.6%	457	406	322	302	40	62
Deferred tax	67.8%	-3.6	-13.3	-3.5	-159.77	239	9.48
Total tax	15.9%	454	392	318	143	280	72
Total profit (loss) for period	15.2%	1,493	1,296	1,010	1,085	665	105
Other comp. income net of taxes	-1475%	-11.6	0.2	-8.5	-11.14	-2.24	-5.58
Total Comprehensive Income	14.3%	1,481	1,296	1,002	1,074	663	100
Earnings Per Share, Basic	15.3%	103.81	90.15	70.28	75.45	46.26	7.51
Earnings Per Share, Diluted	15.2%	103.74	90.15	70.28	75.45	46.26	7.51
Debt equity ratio	-	-	-	-	025	-	082
Debt service coverage ratio	-	-	-	-	0.0231	-	0.0292
Interest service coverage ratio	-	-	-	-	0.0713	-	0.0427

Category	APOLLOHOSP	Healthcare
PE	61.63	64.84
PS	4.71	6.58
Growth	15.6 %	16.1 %

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	66.3%	811	488	578	1,435	506	472
Current investments	-45.9%	1,016	1,878	1,432	698	684	562
Loans, current	-17.6%	2.4	2.7	5.1	3	4.9	5.67
Total current financial assets	-8.7%	6,357	6,963	5,996	6,514	4,304	4,117
Inventories	7.3%	542	505	481	448	460	423
Current tax assets	-100.5%	0	208	0	-	-	252
Total current assets	-14%	6,900	8,023	7,029	7,338	5,280	5,140
Property, plant and equipment	10.8%	11,039	9,965	9,816	9,043	8,540	7,771
Capital work-in-progress	-3.3%	992	1,026	771	1,042	845	727
Investment property	-20%	2.2	2.5	2.8	3.1	3.4	3.75
Goodwill	0%	1,032	1,032	1,030	1,012	1,012	1,011
Non-current investments	0.4%	906	902	830	314	104	290
Loans, non-current	-58.3%	16	37	27	31	6.6	6.9
Total non-current financial assets	23.2%	1,470	1,193	1,070	629	363	614
Total non-current assets	9.8%	15,297	13,927	13,628	12,210	11,473	10,421
Total assets	1.1%	22,197	21,950	20,657	19,548	16,753	15,561
Borrowings, non-current	-45.8%	2,430	4,483	4,417	3,819	2,236	2,016
Total non-current financial liabilities	-26.8%	5,130	7,011	6,862	6,081	4,227	4,409
Provisions, non-current	-3.9%	100	104	89	81	73	56
Total non-current liabilities	-24.8%	5,741	7,633	7,426	6,632	4,768	4,904
Borrowings, current	276.5%	3,228	858	858	1,029	926	994
Total current financial liabilities	39.8%	5,975	4,275	4,134	4,568	4,283	3,342
Provisions, current	0%	195	195	179	166	143	174
Current tax liabilities	-5.9%	2.6	2.7	1.6	0.8	1.3	4.05
Total current liabilities	36%	6,481	4,764	4,579	5,001	4,664	3,780
Total liabilities	-1.4%	12,222	12,397	12,004	11,633	9,433	8,683
Equity share capital	0%	72	72	72	72	72	72
Non controlling interest	7.4%	494	460	441	414	385	369
Total equity	4.4%	9,974	9,553	8,653	7,915	7,320	6,878
Total equity and liabilities	1.1%	22,197	21,950	20,657	19,548	16,753	15,561

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	120.6%	343	156	233	325	276	254
Current investments	-45.9%	1,016	1,878	1,432	697	684	562
Loans, current	516.7%	75	13	22	113	79	80
Total current financial assets	-26.3%	2,704	3,669	3,143	3,054	3,280	3,186
Inventories	10.6%	147	133	127	127	119	112
Current tax assets	-104.8%	0	22	0	-	-	63
Total current assets	-29.3%	2,850	4,032	3,518	3,372	3,675	3,506
Property, plant and equipment	8.3%	6,822	6,299	6,239	5,953	5,971	5,355
Capital work-in-progress	-22.6%	302	390	294	295	172	97
Goodwill	-	0	0	0	0	0	0
Non-current investments	53.6%	3,877	2,525	2,479	2,467	1,938	1,938
Loans, non-current	3.7%	559	539	429	360	245	225
Total non-current financial assets	50.3%	4,828	3,212	3,061	2,985	2,361	2,400
Total non-current assets	19%	12,064	10,135	9,854	9,478	8,730	7,994
Total assets	5.3%	14,914	14,167	13,372	12,850	12,405	11,500
Borrowings, non-current	2.5%	1,625	1,586	1,554	1,681	1,786	1,621
Total non-current financial liabilities	2.3%	2,954	2,889	2,833	2,841	2,944	2,577
Total non-current liabilities	1.4%	3,310	3,263	3,197	3,216	3,324	2,949
Borrowings, current	-5.8%	197	209	230	205	170	175
Total current financial liabilities	4.2%	1,354	1,300	1,181	1,207	1,161	1,035
Provisions, current	-22.3%	109	140	128	123	101	123
Total current liabilities	3.3%	1,642	1,589	1,441	1,444	1,370	1,257
Total liabilities	2%	4,951	4,852	4,638	4,659	4,694	4,206
Equity share capital	0%	72	72	72	72	72	72
Total equity	7%	9,963	9,315	8,734	8,190	7,711	7,294
Total equity and liabilities	5.3%	14,914	14,167	13,372	12,850	12,405	11,500

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Finance costs	-1.8%	450	458	449	381	379	-
Change in inventories	-182.3%	-61.1	-21	-69.2	42	-175.76	-
Depreciation	15.6%	876	758	687	615	601	-
Impairment loss / reversal	-200%	0	2	0	0	1.78	-
Unrealised forex losses/gains	-33.3%	-0.2	0.1	0.1	-0.29	-0.55	-
Dividend income	666.7%	2.7	0.7	0	0	0	-
Adjustments for interest income	-19.8%	74	92	43	44	35	-
Share-based payments	41.1%	159	113	88	76	2.56	-
Net Cashflows from Operations	31.6%	3,461	2,630	2,387	1,759	1,820	-
Income taxes paid (refund)	22.7%	606	494	467	382	204	-
Net Cashflows From Operating Activities	33.7%	2,856	2,136	1,920	1,377	1,616	-
Cashflows used in obtaining control of subsidiaries	-	1,300	0	3.7	50	100	-
Proceeds from sales of PPE	114.3%	31	15	1.9	4.07	0	-
Purchase of property, plant and equipment	14.5%	1,962	1,713	1,137	1,129	657	-
Proceeds from sales of investment property	-	0	0	0	0	5.4	-
Proceeds from sales of long-term assets	-	0	0	817	0	0	-
Purchase of other long-term assets	-	0	0	1,171	0	0	-
Cash receipts from repayment of advances and loans made to other parties	251.4%	27	8.4	16	2.98	11	-
Dividends received	25%	12	9.8	0	5.04	0	-
Interest received	0%	84	84	39	44	36	-
Other inflows (outflows) of cash	375.6%	979	-353.8	-85.9	49	-153.66	-
Net Cashflows From Investing Activities	36.4%	-2,148.2	-3,380.6	-1,537.1	-856.85	-790.73	-
Proceeds from changes in ownership interests in subsidiaries	-	0	0	0	4.54	0	-
Payments from changes in ownership interests in subsidiaries	-171.4%	0	2.4	14	0	1	-
Proceeds from issuing shares	-102.2%	0	46	2.4	0	0	-
Proceeds from issuing other equity instruments	-	2.6	0	0	0	0	-
Proceeds from borrowings	-56.3%	1,115	2,551	707	585	426	-
Repayments of borrowings	66.2%	734	442	254	516	712	-
Payments of lease liabilities	13.7%	291	256	0	197	60	-
Dividends paid	5.4%	293	278	221	258	43	-
Interest paid	-8%	278	302	303	251	376	-
Other inflows (outflows) of cash	-	0	1	0	0	0	-
Net Cashflows from Financing Activities	-136.4%	-477.6	1,317	-311.2	-633.33	-767.7	-
Net change in cash and cash eq.	218.1%	230	73	72	-113.13	57	-

Description	(%) Q/Q	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024
Revenue From Operations	3.1%	2,438	2,364	2,356	2,168	2,075	2,055
Other Income	-16.8%	90	108	141	32	92	108
Total Income	2.3%	2,529	2,472	2,497	2,200	2,167	2,163
Cost of Materials	-1%	606	612	611	590	562	569
Employee Expense	7.6%	441	410	431	404	410	394
Finance costs	1.6%	63	62	58	59	63	62
Depreciation and Amortization	0.8%	128	127	122	123	130	108
Other expenses	6.4%	796	748	721	628	582	580
Total Expenses	3.8%	2,034	1,959	1,944	1,804	1,747	1,713
Profit Before exceptional items and Tax	-3.7%	494	513	554	397	420	449
Exceptional items before tax	91.9%	0	-11.4	0	0	0	0
Total profit before tax	-1.6%	494	502	554	397	420	449
Current tax	29.2%	138	107	123	89	99	105
Deferred tax	-347.3%	-26.2	12	11	0.4	-12.6	2.6
Total tax	-5.1%	112	118	134	90	87	108
Total profit (loss) for period	-0.5%	382	384	420	307	333	342
Other comp. income net of taxes	-129.4%	-6.8	-2.4	-8.1	5.7	0.1	-2.5
Total Comprehensive Income	-1.3%	376	381	412	313	334	339
Earnings Per Share, Basic	-0.3%	26.59	26.67	29.2	21.35	23.18	23.76
Earnings Per Share, Diluted	-0.4%	26.56	26.67	29.2	21.35	23.18	23.76
Debt equity ratio	-	-	-	-	-	-	-
Debt service coverage ratio	-	-	-	-	-	-	-
Interest service coverage ratio	-	-	-	-	-	-	-

APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

APOLLOHOSP

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

APOLLOHOSP

APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

APOLLOHOSP

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

APOLLOHOSP

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Apollo Hospitals Enterprises Ltd. do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Apollo Hospitals Enterprises Ltd. do?

Important Disclosure & Data Context